Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Identification of suitable reference genes for peripheral blood mononuclear cell subset studies in multiple sclerosis.
Neutralizing Nanobodies targeting diverse chemokines effectively inhibit chemokine function.
Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage.
Genetic control of nerve conduction velocity may influence multiple sclerosis phenotype.
Dendritic cells and multiple sclerosis: disease, tolerance and therapy.
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
Suppression of the lipid peroxidation process in the CNS reduces neurological expression of experimentally induced autoimmune encephalomyelitis.
Pulmonary Hypertension and Multiple Sclerosis - Coincidence or Association?
Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study.
[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats].
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
ENCOMS: Argentinian survey in cost of illness and unmet needs in multiple sclerosis.
A phase-specific neuroimmune model of clinical depression.
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders.
How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?-Reply.
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation.
Myelination at a glance.
Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
Evaluating cognitive rehabilitation in multiple sclerosis: on the bumpy road to establishing evidence.
How can we exploit the brain's ability to repair itself?
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer.
New Microparticle Secondary Progressive MS Therapy Dosing Tested In Australian Clinical Trial
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
Pages
« first
‹ previous
…
221
222
223
224
225
226
227
228
229
…
next ›
last »